Abstract

Minimal-invasive techniques are increasingly applied in clinical practice and have contributed towards improving postoperative outcomes. While comparing favorably with open surgery in terms of safety, the occurrence of severe complications remains a grave concern. To date, no objective predictive system has been established to guide clinicians in estimating complication risks as the relative contribution of general patient health, liver function and surgical parameters remain unclear. Here, we perform a single-center analysis of all consecutive patients undergoing laparoscopic liver resection for primary hepatic malignancies since 2010. Among the 210 patients identified, 32 developed major complications. Several independent predictors were identified through a multivariate analysis, defining a preoperative model: diabetes, history of previous hepatectomy, surgical approach, alanine aminotransferase levels and lesion entity. The addition of operative time and whether conversion was required significantly improved predictions and were thus incorporated into the postoperative model. Both models were able to identify patients with major complications with acceptable performance (area under the receiver-operating characteristic curve (AUC) for a preoperative model = 0.77 vs. postoperative model = 0.80). Internal validation was performed and confirmed the discriminatory ability of the models. An easily accessible online tool was deployed in order to estimate probabilities of severe complication without the need for manual calculation.

Highlights

  • Liver resection is the primary option for the curative treatment of hepatic malignancies [1,2,3]

  • The majority of resections were performed for hepatocellular carcinoma (HCC) (73.8%) and intrahepatic cholangiocarcinoma (iCC) (20.0%)

  • Liver function was well compensated in the included patients, as accounted for by Child–Pugh scores up to B7 in all cases and a median MELD score of 8

Read more

Summary

Introduction

Liver resection is the primary option for the curative treatment of hepatic malignancies [1,2,3]. Liver surgery has been thought of as a classical domain of open surgery with the need for large incisions and inherent protracted postoperative courses. This is evident in the case of malignancies, where concerns regarding oncologic outcomes have dampened the widespread application of minimal-invasive techniques. These concerns have been disproven, and laparoscopic liver resection (LLR) is, in select centers, applied as the mainstay treatment option independent of tumor size, entity or location [6,7,8]. LLR has been shown to be an effective method to treat the most common primary hepatic malignancies, hepatocellular carcinoma (HCC) [9] and intrahepatic cholangiocarcinoma (iCC) [10,11]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.